Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Betz

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Tissue Engineering. Part A|December 29, 2009
The repair of critical-sized bone defects using expedited, autologous BMP-2 gene-activated fat implantsOliver B Betz, Volker M Betz, Ahmed Abdulazim, et al.
Gene Therapy|April 27, 2007
Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defectsO B Betz, V M Betz, A Nazarian, et al.
The Journal of Gene Medicine|July 27, 2017
BMP-2 gene activated muscle tissue fragments for osteochondral defect regeneration in the rabbit kneeVolker M Betz, Alexander Keller, Peter Foehr, et al.
The Journal of Bone and Joint Surgery. American Volume|February 3, 2006
Direct percutaneous gene delivery to enhance healing of segmental bone defectsOliver B Betz, Volker M Betz, Ara Nazarian, et al.
Acta Neurochirurgica|November 24, 2015
Gene-activated fat grafts for the repair of spinal cord injury: a pilot studyVolker M Betz, K Hakan Sitoci-Ficici, Ortrud Uckermann, et al.
Oncogene|February 2, 2006
Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosisJ Veeck, D Niederacher, H An, et al.
Injury|October 12, 2015
The effect of BMP-7 gene activated muscle tissue implants on the repair of large segmental bone defectsVolker M Betz, Oliver B Betz, Tom Rosin, et al.
The Journal of Gene Medicine|July 5, 2016
An expedited approach for sustained delivery of bone morphogenetic protein-7 to bone defects using gene activated fragments of subcutaneous fatVolker M Betz, Oliver B Betz, Tom Rosin, et al.
Journal of Viral Hepatitis|March 4, 2017
Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p studyE B Cunningham, B Hajarizadeh, N A Bretana, et al.
Arthritis Research & Therapy|August 23, 2003
A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transferJean-Noel Gouze, Elvire Gouze, Glyn D Palmer, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Tissue Engineering. Part A|December 29, 2009
The repair of critical-sized bone defects using expedited, autologous BMP-2 gene-activated fat implantsOliver B Betz, Volker M Betz, Ahmed Abdulazim, et al.
Gene Therapy|April 27, 2007
Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defectsO B Betz, V M Betz, A Nazarian, et al.
The Journal of Gene Medicine|July 27, 2017
BMP-2 gene activated muscle tissue fragments for osteochondral defect regeneration in the rabbit kneeVolker M Betz, Alexander Keller, Peter Foehr, et al.
The Journal of Bone and Joint Surgery. American Volume|February 3, 2006
Direct percutaneous gene delivery to enhance healing of segmental bone defectsOliver B Betz, Volker M Betz, Ara Nazarian, et al.
Acta Neurochirurgica|November 24, 2015
Gene-activated fat grafts for the repair of spinal cord injury: a pilot studyVolker M Betz, K Hakan Sitoci-Ficici, Ortrud Uckermann, et al.
Oncogene|February 2, 2006
Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosisJ Veeck, D Niederacher, H An, et al.
Injury|October 12, 2015
The effect of BMP-7 gene activated muscle tissue implants on the repair of large segmental bone defectsVolker M Betz, Oliver B Betz, Tom Rosin, et al.
The Journal of Gene Medicine|July 5, 2016
An expedited approach for sustained delivery of bone morphogenetic protein-7 to bone defects using gene activated fragments of subcutaneous fatVolker M Betz, Oliver B Betz, Tom Rosin, et al.
Journal of Viral Hepatitis|March 4, 2017
Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p studyE B Cunningham, B Hajarizadeh, N A Bretana, et al.
Arthritis Research & Therapy|August 23, 2003
A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transferJean-Noel Gouze, Elvire Gouze, Glyn D Palmer, et al.
Pageof 8